USFDA Approves Sales Of Aurobindo Pharma�s Ulcer Drug In The Market
The Ulcer durg, Omeprazole delayed-release capsules, are indicated for short-term treatment of active duodenal ulcer in adults received approval from FDA.
The Ulcer durg, Omeprazole delayed-release capsules, are indicated for short-term treatment of active duodenal ulcer in adults received approval from FDA.
"... the launch of these two products will lower the daily cost of treatment for a diabetes patient on Gliptin therapy by approximately 55 percent," Vasudevan said. Glenmark's diabetes segment is valued at around Rs 100 crore, Vasudevan said, adding it is growing at 20 percent per annum.
Reacting to a query, he said, "The capex for this year is Rs 600 crore and majority of this will go for the plant in the US."
USFDA Approved Lupin's Anti-Cholesterol Drug may Not Fatten Up Firm Financials
Lupin Ltd's anti-cholesterol drug is highly competitive and hence unlikely to contribute significantly to the company, though its getting approval is positive.
Lupin Ltd's anti-cholesterol drug is highly competitive and hence unlikely to contribute significantly to the company, though its getting approval is positive.
Mumbai-Based Drug Firm Gets USFDA Approval For Acne Treatment Medicine
Sun Pharma’s XiminoTM capsules are indicated for inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years and above.
Sun Pharma’s XiminoTM capsules are indicated for inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years and above.
Glenmark�s Patent Plea For Skin Care Drug Rejected By The US District Court Of Delaware
The court came to the conclusion that Glenmark had infringed the 070 patent of the plaintiffs and ordered the judgment in favor of Bayer and other plaintiffs.
The court came to the conclusion that Glenmark had infringed the 070 patent of the plaintiffs and ordered the judgment in favor of Bayer and other plaintiffs.
